← FDA Drug Approvals (Drugs@FDA)
SUCRALFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS US · Approved 2025-04-14
Drug application
- FDA Application #
ANDA211780- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SUCRALFATE
- Generic name
- Sucralfate
- Active ingredients
- SUCRALFATE
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- PADAGIS US
- First approval
- 2025-04-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown